Cited by 217Global Cancer Incidence and ScreeningDigital Radiography and Breast ImagingWomen's cancer prevention and management

Consequences of false-positive screening mammograms

Open access
Tosteson, Anna N. A., Fryback, Dennis G., Hammond, Cristina S., Hanna, Lucy G., Grove, Margaret R., Brown, Mary, Wang, Qianfei, Lindfors, Karen +1 more·2014·JAMA Internal Medicine

Abstract

IMPORTANCE: False-positive mammograms, a common occurrence in breast cancer screening programs, represent a potential screening harm that is currently being evaluated by the US Preventive Services Task Force. OBJECTIVE: To measure the effect of false-positive mammograms on quality of life by measuring personal anxiety, health utility, and attitudes toward future screening. DESIGN, SETTING, AND PARTICIPANTS: The Digital Mammographic Imaging Screening Trial (DMIST) quality-of-life substudy telephone survey was performed shortly after screening and 1 year later at 22 DMIST sites and included randomly selected DMIST participants with positive and negative mammograms. EXPOSURE: Mammogram requiring follow-up testing or referral without a cancer diagnosis. MAIN OUTCOMES AND MEASURES: The 6-question short form of the Spielberger State-Trait Anxiety Inventory state scale (STAI-6) and the EuroQol EQ-5D instrument with US scoring. Attitudes toward future screening as measured by women's self-report of future intention to undergo mammographic screening and willingness to travel and stay overnight to undergo a hypothetical new type of mammography that would identify as many cancers with half the false-positive results. RESULTS: Among 1450 eligible women invited to participate, 1226 (84.6%) were enrolled, with follow-up interviews obtained in 1028 (83.8%). Anxiety was significantly higher for women with false-positive mammograms (STAI-6, 35.2 vs 32.7), but health utility scores did not differ and there were no significant differences between groups at 1 year. Future screening intentions differed by group (25.7% vs 14.2% more likely in false-positive vs negative groups); willingness to travel and stay overnight did not (9.9% vs 10.5% in false-positive vs negative groups). Future screening intention was significantly increased among women with false-positive mammograms (odds ratio, 2.12; 95% CI, 1.54-2.93), younger age (2.78; 1.5-5.0), and poorer health (1.63; 1.09-2.43). Women's anticipated high-level anxiety regarding future false-positive mammograms was associated with willingness to travel overnight (odds ratio, 1.94; 95% CI, 1.28-2.95). CONCLUSIONS AND RELEVANCE: False-positive mammograms were associated with increased short-term anxiety but not long-term anxiety, and there was no measurable health utility decrement. False-positive mammograms increased women's intention to undergo future breast cancer screening and did not increase their stated willingness to travel to avoid a false-positive result. Our finding of time-limited harm after false-positive screening mammograms is relevant for clinicians who counsel women on mammographic screening and for screening guideline development groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2014.981

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • STAI has been used in breast, colon, and lung cancer screening programs and in patients with cirrhosis.

    “which has been used in breast, colon, and lung cancer screening programs24–26 and in patients with cirrhosis.27”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [26]Hendrick RE Lewin JM D’Orsi C Yaffe M Non-inferiority study of ffdm in an enriched diagnostic cohort: Comparison with screen-film mammography in 625 women International workshopon digital mammography 2000: 5th international workshop on digital mammography 2001 475 481 Medical Physics Madison, WI et a

Cited by

Sorted by citations

Authors
Tosteson, A. N. A., Fryback, D. G., Hammond, C. S., Hanna, L. G., Grove, M. R., Brown, M., Wang, Q., Lindfors, K., & Pisano, E. D.
Affiliations
  • Dartmouth Institute for Health Policy and Clinical Practice (US)
  • University of Wisconsin–Madison (US)
  • Brown University (US)
  • University of North Carolina at Chapel Hill (US)
  • University of California, Davis (US)
  • Medical University of South Carolina (US)
Corresponding author
Tosteson, Anna N. A.
Venue
JAMA Internal Medicine
Published
2014-06-01
Volume
174
Issue
6
Pages
954
ISSN
2168-6106 (ISSN-L)
OpenAlex
W1997495901
Cited by
217
References
37
Citations by year
2026: 11 · 2025: 20 · 2024: 15 · 2023: 13 · 2022: 22 · 2021: 21 · 2020: 25 · 2019: 13 · 2018: 20 · 2017: 20 · 2016: 19 · 2015: 9 · 2014: 9
FWCI
9.16
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JAMA Internal Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Public Health Service (U0179778-S1)
  • National Cancer Institute (U01CA079778, U10CA180820, U01-CA-80098, U01 CA79778, U54CA163307, U01CA080098, UC2CA148259, U01CA80098-S1, U10CA180794, RC2/UC2CA148259, P30CA023108)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Digital Radiography and Breast Imaging
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords
false-positive mammograms, breast cancer screening, health-related quality of life, health utility, screening intention, USPSTF screening recommendations, state anxiety, EQ-5D
MeSH terms
Aged, Anxiety, False Positive Reactions, Female, Follow-Up Studies, Humans, Mammography, Middle Aged, Quality of Life

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review